Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelm January 12, 2022 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Centers for Medicare and Medicaid Services, elderly, Medicare, your-feed-healthcare 0 If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials.